It’s been awfully quiet on the Orangefiery blog. Too quiet. Fifteen months since our last post? That’s outrageous!

All we can offer is a typical excuse: We’ve been really busy.

It’s true. Business is good and growing. We’ve got a dozen clients and eight team members. The work we’ve taken on has been challenging and rewarding.

By Mike Kuczkowski   It’s been awfully quiet on the Orangefiery blog. Too quiet. Fifteen months since our last post? That’s outrageous! All we can offer is a typical excuse: We’ve been really busy. It’s true. Business is good and growing. We’ve got a dozen clients and eight team members. The work we’ve taken on […]

Photo by Chris Potter, courtesy of http://www.stockmonkeys.com/. Used under Creative Commons license. By Mike Kuczkowski   It was, according to Turing Pharmaceuticals CEO Martin Shkreli, “a great business decision that also benefits all of our stakeholders.” Not so fast, buddy. Shkreli was referring to his company’s decision to raise the price of Daraprim, a treatment for […]

It was, according to Turing Pharmaceuticals CEO Martin Shkreli, “a great business decision that also benefits all of our stakeholders.”

Not so fast, buddy.

Shkreli was referring to his company’s decision to raise the price of Daraprim, a treatment for toxoplasmosis it had recently acquired, from $13.50 to $750 per pill. Some 60 million Americans carry the parasite that causes toxoplasmosis, but most people are unaffected by it. For those with suppressed immune systems, however, like pregnant women or people with AIDS, it can be life threatening.

The pontiff, who visits the US this week, has effectively used symbols in his communications to change the dialogue about the Roman Catholic Church. Photo by Andrea Zangrilli. By Mike Kuczkowski Imagine, if you will, a hypothetical scenario for the 2016 presidential election. After a tough series of primary battles, former Washington Gov. Christine Gregoire[i], is […]

It was January 2004, and I was meeting with my boss when a colleague knocked on the door and popped in. “Hey, did you see ‘The Apprentice’ last night?”

My boss and I looked at each other and smirked. “No.”

The smirk was telling. The program, which was being billed as “The Ultimate Job Interview,” featured real estate magnate Donald Trump and a cast of 16 contestants who vied for a one-year, $250,000 job in Trump’s organization. As a concept, the show sounded like a loser.

To understand Donald Trump’s lead in the polls, look closely at the narrative he’s constructing about himself – and America. Photo by Gage Skidmore. Used under Creative Commons license.   By Mike Kuczkowski It was January 2004, and I was meeting with my boss when a colleague knocked on the door and popped in. “Hey, […]

To understand Donald Trump’s lead in the polls, look closely at the narrative he’s constructing about himself – and America. Photo by lucky-photographer. By Mike Kuczkowski It was January 2004, and I was meeting with my boss when a colleague knocked on the door and popped in. “Hey, did you see ‘The Apprentice’ last night?” […]

By Mike Kuczkowski Today marks the 111th anniversary of the day on which James Joyce first went strolling around Dublin with his future wife, Nora Barnacle. Also, the date on which Joyce imagined a short story taking place that would follow an ad man, Leopold Bloom, around Dublin. Which, Joyce later expanded into the 18-chapter, […]

A chart from LaCour and Green’s study of voter attitudes before and after they spoke with either a gay or straight canvasser about their views on same-sex marriage. These data are now disputed. (Source: Mike LaCour’s web site, accessed May 27, 2015.) By Michael Kuczkowski “… just because the data don’t exist to demonstrate the […]

Tom Brady, who is implicated in an NFL investigation into whether his team intentionally deflated footballs used in the AFC Championship Game in January. Photo by Keith Allison. Used under Creative Commons license. By Mike Kuczkowski In Week 7 of what was a tough 2014 NFL season, Patriots Quarterback Tom Brady was ticked off. It […]

Years ago, I was part of a team that was hired to help a pharmaceutical company explain to America why its industry was a good thing.

This was not an easy task, obviously. The pharmaceutical industry has a weak reputation overall, despite delivering many innovations that improve the health of people around the world. A big chunk of the problem is rooted in costs: People believe health care is a right, yet prescription medications cost money, sometimes a lot of money. With ever-changing insurance co-pays, drug classes and deductibles, individuals increasingly bear the brunt of those costs. Which is tough.